Volume 31, Number 8—August 2025
CME ACTIVITY - Research
Scheffersomyces spartinae Fungemia among Pediatric Patients, Pakistan, 2020–2024
Table 1
Patient demographic and clinical characteristics from cases of Scheffersomyces spartinae fungemia among pediatric patients, Pakistan, 2020–2024
Characteristics |
No. (%), n = 108 |
---|---|
Age group | |
<2 wk | 40 (37.0) |
2–3 wk | 34 (31.5) |
1–6 mo | 5 (4.6) |
7–11 mo | 8 (7.4) |
1–6 y | 14 (13.0) |
7–12 y |
7 (6.5) |
City of residence | |
Karachi | 99 (91.7) |
Lahore | 5 (4.6) |
Nawabshah | 2 (1.9) |
Hafizabad | 1 (0.9) |
Multan |
1 (0.9) |
Isolation year | |
2020 | 16 (14.8) |
2021 | 0 |
2022 | 20 (18.5) |
2023 | 66 (61.1) |
2024 |
6 (5.6) |
Hospital or institution | |
Hospital B | 5 (4.6) |
Hospital H | 75 (69.4) |
Hospital N | 5 (4.6) |
Hospitals with only 1 case | 11 (10.2) |
Unknown hospital |
12 (11.1) |
Clinical details | |
Patient family or guardian contacted | 92 (85.2) |
Hospitalization reported, n = 92 | 92 (100) |
Clinical information available | 63 (58.3) |
Presumed sepsis, n = 63 | 43 (68.2) |
Page created: June 02, 2025
Page updated: July 24, 2025
Page reviewed: July 24, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.